Preconditioning and tolerance against cerebral ischaemia
By U. Dirnagl, K. Becker, A. Meisel. Lancet Neurology, 2009
598 citations recorded by the source corpus.
Neuroprotection and brain repair in patients after acute brain damage are still major unfulfilled medical needs. Pharmacological treatments are either ineffective or confounded by adverse effects. Consequently, endogenous mechanisms by which the brain protects itself against noxious stimuli and recovers from damage are being studied. Research on preconditioning, also known as induced tolerance, over the past decade has resulted in various promising strategies for the treatment of patients with acute brain injury. Several of these strategies are being tested in randomised clinical trials. Additionally, research into preconditioning has led to the idea of prophylactically inducing protection in patients such as those undergoing brain surgery and those with transient ischaemic attack or subarachnoid haemorrhage who are at high risk of brain injury in the near future. In this Review, we focus on the clinical issues relating to preconditioning and tolerance in the brain; specifically, we discuss the clinical situations that might benefit from such procedures. We also discuss whether preconditioning and tolerance occur naturally in the brain and assess the most promising candidate strategies that are being investigated.
Subfields: Critical Care and Intensive Care Medicine, Developmental Neuroscience, Neurology
View Paper: https://www.semanticscholar.org/paper/f57760f770997323e5e59a19b447ad6ae76e91f5
Citations in the corpus
- Brain metabolism in health, aging, and neurodegeneration (2017, unknown): “…in vivo is ischemic preconditioning in which rats or mice that are subjected to a mild cerebral ischemia prior to full-blown ischemic stroke exhibit reduced brain cell damage and improved functional outcome compared to animals not subjected to the preconditioning ischemia (Dirnagl et al, 2009).”